Molecular basis of juvenile myelomonocytic leukemia.
作者信息
de Vries Andrica C H, Zwaan C Michael, van den Heuvel-Eibrink Marry M
出版信息
Haematologica. 2010 Feb;95(2):179-82. doi: 10.3324/haematol.2009.016865.
Abstract
摘要
相似文献
1
Molecular basis of juvenile myelomonocytic leukemia.青少年粒单核细胞白血病的分子基础
Haematologica. 2010 Feb;95(2):179-82. doi: 10.3324/haematol.2009.016865.
2
[Myelodysplastic syndrome in children].[儿童骨髓增生异常综合征]
Rinsho Ketsueki. 2009 Oct;50(10):1560-9.
3
Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia.Ras 通路中的基因突变与韩国青少年骨髓单核细胞白血病患者的预后意义。
Ann Hematol. 2012 Apr;91(4):511-7. doi: 10.1007/s00277-011-1326-9. Epub 2011 Sep 8.
4
CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.青少年骨髓单核细胞白血病和儿童骨髓增生异常综合征中的CBL突变
Leukemia. 2010 May;24(5):1090-2. doi: 10.1038/leu.2010.49. Epub 2010 Apr 1.
5
After 95 years, it's time to eRASe JMML.95 年后，是时候消灭 JMML 了。
Blood Rev. 2020 Sep;43:100652. doi: 10.1016/j.blre.2020.100652. Epub 2020 Jan 16.
6
Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia.青少年粒单核细胞白血病临床特征与GM-CSF信号通路相关基因突变状态的相关性
Pediatr Res. 2009 Mar;65(3):334-40. doi: 10.1203/PDR.0b013e3181961d2a.
7
Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.一名患有此前未被怀疑的1型神经纤维瘤病和青少年粒单核细胞白血病的儿童患幼年性黄色肉芽肿。
Pediatr Blood Cancer. 2010 Jan;54(1):173-5. doi: 10.1002/pbc.22297.
8
Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.青少年骨髓单核细胞白血病：第二届国际青少年骨髓单核细胞白血病研讨会报告
Leuk Res. 2009 Mar;33(3):355-62. doi: 10.1016/j.leukres.2008.08.022. Epub 2008 Oct 26.
9
Germline mutation of CBL is associated with moyamoya disease in a child with juvenile myelomonocytic leukemia and Noonan syndrome-like disorder.胚系 CBL 突变与儿童青少年骨髓单核细胞白血病伴努南综合征样疾病相关的烟雾病。
Pediatr Blood Cancer. 2015 Mar;62(3):542-4. doi: 10.1002/pbc.25271. Epub 2014 Oct 4.
10
Neurofibromatosis type 1 diagnosed in a child based on multiple juvenile xanthogranulomas and juvenile myelomonocytic leukemia.基于多发性幼年黄色肉芽肿和幼年型粒单核细胞白血病在一名儿童中诊断出1型神经纤维瘤病。
Pediatr Dermatol. 2015 Jan-Feb;32(1):e29-32. doi: 10.1111/pde.12478. Epub 2014 Dec 16.
引用本文的文献
1
Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study.基于地西他滨的治疗策略改善了 JMML 患者 HSCT 的预后：一项回顾性队列研究。
Front Immunol. 2024 Aug 26;15:1426640. doi: 10.3389/fimmu.2024.1426640. eCollection 2024.
2
Epigenetic Profiling of Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape.突变型幼年型粒单核细胞白血病造血干细胞和祖细胞的表观遗传分析揭示了异常的组蛋白格局。
Cancers (Basel). 2023 Oct 29;15(21):5204. doi: 10.3390/cancers15215204.
3
Potential value of high-throughput single-cell DNA sequencing of Juvenile myelomonocytic leukemia: report of two cases.高通量单细胞 DNA 测序在幼年髓单核细胞白血病中的潜在价值：两例报告。
NPJ Syst Biol Appl. 2023 Sep 9;9(1):41. doi: 10.1038/s41540-023-00303-7.
4
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia.阿扎胞苷和 MEK 抑制剂联合治疗在 PTPN11 突变型幼年骨髓单核细胞白血病中的潜在临床应用。
Mol Ther. 2023 Apr 5;31(4):986-1001. doi: 10.1016/j.ymthe.2023.01.030. Epub 2023 Feb 3.
5
Inhibition of BTK and PI3Kδ impairs the development of human JMML stem and progenitor cells.抑制 BTK 和 PI3Kδ 会损害人类 JMML 干细胞和祖细胞的发育。
Mol Ther. 2022 Jul 6;30(7):2505-2521. doi: 10.1016/j.ymthe.2022.04.009. Epub 2022 Apr 20.
6
Physiological and Aberrant γ-Globin Transcription During Development.发育过程中的生理性和异常性γ-珠蛋白转录
Front Cell Dev Biol. 2021 Apr 1;9:640060. doi: 10.3389/fcell.2021.640060. eCollection 2021.
7
Pediatric Neoplasms Presenting with Monocytosis.以单核细胞增多为表现的小儿肿瘤。
Curr Hematol Malig Rep. 2021 Jun;16(3):235-246. doi: 10.1007/s11899-021-00611-x. Epub 2021 Feb 25.
8
Cleaning up the environment in juvenile myelomonocytic leukemia.清理青少年骨髓单核细胞白血病的环境。
Transl Cancer Res. 2017 Feb;6(Suppl 1):S36-S38. doi: 10.21037/tcr.2017.02.06.
9
[Advances in the treatment of juvenile myelomonocytic leukemia].[青少年粒单核细胞白血病的治疗进展]
Zhongguo Dang Dai Er Ke Za Zhi. 2018 Nov;20(11):958-963. doi: 10.7499/j.issn.1008-8830.2018.11.016.
10
Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy.染色质调控因子 Asxl1 缺失和 Nf1 杂合性缺失协同加速髓系恶性肿瘤。
J Clin Invest. 2018 Dec 3;128(12):5383-5398. doi: 10.1172/JCI121366. Epub 2018 Oct 29.
本文引用的文献
1
Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.有丝分裂重组和复合杂合突变是儿童青少年骨髓单核细胞白血病合并 1 型神经纤维瘤病中 NF1 失活的主要机制。
Haematologica. 2010 Feb;95(2):320-3. doi: 10.3324/haematol.2009.010355. Epub 2009 Dec 16.
2
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.CBL基因的突变在青少年骨髓单核细胞白血病中频繁发生。
Blood. 2009 Aug 27;114(9):1859-63. doi: 10.1182/blood-2009-01-198416. Epub 2009 Jul 1.
3
Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7.一名患有青少年粒单核细胞白血病和7号染色体单体的患者对阿扎胞苷产生的有趣反应。
Blood. 2009 Mar 19;113(12):2867-8. doi: 10.1182/blood-2008-12-195693.
4
PTEN deficiency is a common defect in juvenile myelomonocytic leukemia.PTEN基因缺失是青少年粒单核细胞白血病中的常见缺陷。
Leuk Res. 2009 May;33(5):671-7. doi: 10.1016/j.leukres.2008.09.036. Epub 2008 Nov 17.
5
Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.青少年骨髓单核细胞白血病：第二届国际青少年骨髓单核细胞白血病研讨会报告
Leuk Res. 2009 Mar;33(3):355-62. doi: 10.1016/j.leukres.2008.08.022. Epub 2008 Oct 26.
6
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates.单细胞分析确定了髓系恶性肿瘤中异常的STAT5激活，并与特定的临床和生物学特征相关。
Cancer Cell. 2008 Oct 7;14(4):335-43. doi: 10.1016/j.ccr.2008.08.014.
7
RAS pathway mutations in juvenile myelomonocytic leukemia.青少年粒单核细胞白血病中的RAS通路突变
Acta Haematol. 2008;119(4):207-11. doi: 10.1159/000140632. Epub 2008 Jun 20.
8
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.在缺乏神经纤维瘤病证据的儿童T细胞急性淋巴细胞白血病和急性髓细胞白血病患者中与白血病相关的NF1基因失活
Blood. 2008 Apr 15;111(8):4322-8. doi: 10.1182/blood-2007-06-095075. Epub 2008 Jan 2.
9
Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia.青少年骨髓单核细胞白血病中BRAF癌基因的突变分析。
Haematologica. 2007 Nov;92(11):1574-5. doi: 10.3324/haematol.11493.
10
Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia.FLT3的突变非依赖性组成性激活在青少年粒单核细胞白血病中的作用。
Haematologica. 2007 Nov;92(11):1557-60. doi: 10.3324/haematol.11201.
Zotero 插件